The Patent Finder
US

Solid Salt Form of Alpha-6-MPEG6-O-Hydroxycodone as Opioid Agonists and Uses Thereof

US 9,682,988 In force
OverviewFamilyAssignmentsSources & methods

Also listed on Inheris Biopharma, Inc., an earlier holder on the record. The recorded assignments below show how it moved.

Term ends Oct 29, 2033 · High confidence

Filed Apr 29, 2015 as application 14/439,473 · Granted Jun 20, 2017
Base term, 20 years from filing
Today
20 years from filing
2013 2033
Clock starts
Oct 29, 2013
Term ends
Oct 29, 2033
Granted
Jun 20, 2017
base term fee events Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. 2 of 3 maintenance fees are paid so far. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Oct 29, 2013, when application PCT/US2013/067273, the earliest non-provisional in its chain, was filed (this one was filed Apr 29, 2015)Oct 29, 2033High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderOct 29, 2033High confidence

This family

Application PCT/US2013/067273PCT application
no patent term
no patent term
US 9,682,988this patent
Oct 2033
Oct 2033
Application 15/498,308Abandoned
not computed
not computed
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 2, 2015
Reel 35767, frame 695
Nektar TherapeuticsWells Fargo Bank, National Association, as Collateral AgentSecurity Interest
Oct 6, 2015
Reel 36796, frame 562
Nektar TherapeuticsTC Lending, LLC, as Collateral AgentGrant of Security Interest in United States Patents
Oct 14, 2015
Reel 36855, frame 686
Wells Fargo Bank, National Association, as Collateral AgentNektar TherapeuticsRelease of Security Interest Recorded at Reel 35767, Frame 0695
Mar 29, 2017
Reel 41784, frame 1
Gadiraju, Ramakrishna; Kowalczyk, Bruce Andrew; Kuklis, Gabriel ChristianNektar TherapeuticsAssignment of Assignor's Interest
Mar 29, 2017
Reel 41784, frame 136
Andres, Patricia; Datar, YogeshAmri Ssci, LLCAssignment of Assignor's Interest
Mar 30, 2017
Reel 41801, frame 707
Amri Ssci, LLCNektar TherapeuticsAssignment of Assignor's Interest
Apr 12, 2017
Reel 41982, frame 433
Mirmehrabi, Mahmoud; Paschalides, NicholasJohnson Matthey Pharmaceutical Materials, Inc. D/B/A Johnson Matthey Pharma ServicesAssignment of Assignor's Interest
Apr 20, 2017
Reel 42084, frame 318
Johnson Matthey Pharmaceutical Materials, Inc. D/B/A Johnson Matthey Pharma ServicesNektar TherapeuticsAssignment of Assignor's Interest
Oct 28, 2019
Reel 50846, frame 461
Nektar TherapeuticsInheris Pharmaceuticals, Inc.Assignment of Assignor's Interest
Oct 28, 2019
Reel 50846, frame 940
Inheris Pharmaceuticals, Inc.TC Lending, LLC, as Collateral AgentSecurity Interest
Nov 15, 2019
Reel 51038, frame 585
Inheris Pharmaceuticals, Inc.Inheris Biopharma, Inc.Change of Name
Apr 17, 2020
Reel 52435, frame 62
TC Lending, LLC, as Collateral AgentInheris Biopharma, Inc.Release of Security Interest
Apr 17, 2020
Reel 53180, frame 9
TC Lending, LLC, as Collateral AgentNektar TherapeuticsRelease of Security Interest
Jan 9, 2023
Reel 62313, frame 501
Inheris Biopharma, Inc.Nektar TherapeuticsAssignment of Assignor's Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited